$4.81
▼ -2.5% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Curis (CRIS) Stock Sees Fair Value Lift As Analysts Back Leadership And Consumer Focus
Curis shares surge after updated emavusertib data strengthens clinical outlook (NASDAQ:CRIS)
Curis Announces Positive Emavusertib Update
Overview
52-week range
$0.46
$3.13
100% of range
Avg surprise (last 3)
-167.2%
Avg reaction (last 2)
-5.3%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-1.25 | $-0.19 | -557.9% | 0.0% | 0.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.49 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-0.68 | $-1.99 | +65.8% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $-1.25 | $-1.14 | -9.7% | — | -10.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.70 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-2.05 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-2.13 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-2.47 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | -$5.80 | -$13.60 | +57.4% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-12M | — | $-7M | $-8M | $-10M | — | $-11M | $-13M |
| Net income | $-24M | — | $-8M | $-9M | $-11M | — | $-10M | $-12M |
| EPS (diluted) | $-1.25 | — | $-0.49 | $-0.68 | $-1.25 | — | $-1.70 | $-2.03 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $5M | $9M | $10M | $20M | $20M | $21M | $10M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $17M | $7M | $14M | $14M | $25M | $26M | $27M | $35M |
| Total assets | $30M | $20M | $28M | $29M | $39M | $41M | $42M | $50M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $17M | $15M | $42M | $43M | $46M | $47M | $51M | $51M |
| Total equity | $13M | $5M | $-15M | $-14M | $-7M | $-6M | $-9M | $-694,000 |
Implied volatility — last 90 days
No IV snapshots yet for CRIS.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.